Core elements of epilepsy diagnosis and management: Expert consensus from the Leadership in Epilepsy, Advocacy, and Development (LEAD) faculty

Current Medical Research and Opinion

Volumn 24, Issue 12, 2008, Pages 3463-3477

  Glauser, Tracy A ^a   Sankar, Raman ^b   Bainbridge, Jacquelyn ^c   Bebin, Martina ^d   Benbadis, Selim R ^e   Cantrell, Deborah T C ^f   Faught Jr , R Edward ^d   Gruenthal, Michael ^g   Hershkowitz, Laura L ^h   Holmes, Gregory L ⁱ   Husain, Aatif M ^j   Labiner, David M ^k   Montouris, Georgia ^l   Naritoku, Dean K ^m   Olson, Barbara J ⁿ   Pellock, John M ^o   Penovich, Patricia E ^p   Privitera, Michael D ^q   Ramsay, R Eugene ^r   Rho, Jong M ^s   Richards, Karen C ^t   Rosenfeld, William E ^u   Slater, Jeremy D ^v   Smith, Michael C ^w   Spitz, Mark C ^c   Stern, John M ^b   Vossler, David ^x   Wheless, James W ^y   more..

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e UNIVERSITY OF SOUTH FLORIDA   (United States)

^f North Texas Neuroscience Center   (United States)

^g ALBANY MEDICAL CENTER   (United States)

^h Northshore Clinical Associates   (United States)

ⁱ DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^j DUKE UNIVERSITY MEDICAL CENTER   (United States)

^k UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^l BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ Pediatrics   (United States)

^o VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^p MINNESOTA EPILEPSY GROUP   (United States)

^q UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^r UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^s BARROW NEUROLOGICAL INSTITUTE   (United States)

^t Specially for Children   (United States)

^u Comprehensive Epilepsy Care Center for Children and Adults ^*  (United States)

^v UNIVERSITY OF TEXAS   (United States)

^w RUSH UNIVERSITY MEDICAL CENTER   (United States)

^x Washington Neuroscience Institute   (United States)

^y UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

more..

Author keywords

Consensus development; Disease management; Epilepsy; Long term care; Practice recommendations

Indexed keywords

ANTICONVULSIVE AGENT;

CAREGIVER; CLINICAL DECISION MAKING; CLINICAL EVALUATION; CLINICAL PRACTICE; CONSENSUS; DIAGNOSTIC TEST; DISEASE EXACERBATION; ELECTROENCEPHALOGRAPHY; EPILEPSY; HEALTH CARE MANAGEMENT; HEALTH SURVEY; HISTORY; HUMAN; KETOGENIC DIET; LEADERSHIP; MEDICAL SCHOOL; NEUROLOGIC EXAMINATION; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CARE; PATIENT MONITORING; PRIMARY MEDICAL CARE; QUALITY OF LIFE; ARTICLE; DIFFERENTIAL DIAGNOSIS; FEMALE; MALE;

CONSENSUS; DIAGNOSIS, DIFFERENTIAL; EPILEPSY; FACULTY, MEDICAL; FEMALE; HUMANS; MALE;

EID: 62349131524     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007990802561148     Document Type: Note

References (24)

1. US Department of Health and Human Services Center for Disease Control and Prevention. Targeting epilepsy: one of the nation's most common disabling neurological conditions 2007. Revised April 2007. http://www.cdc.gov/nccdphp/ publications/AAG/epilepsy.htm. Accessed February 13, 2008
2. Glauser T, Ben-Menachem E, Bourgeois B, et al. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 2006;47:1094-1120 (Pubitemid 44086745)
3. Scottish Intercollegiate Guidelines Network. Diagnosis and management of epilepsy in adults: a national clinical guideline. Edinburgh, Scotland: Royal College of Physicians, April 2003. Available at: www.sign.ac.uk/guidelines/ fulltext/70/index.html [Last accessed 19 February 2008]
4. US Department of Health and Human Services Center for Disease Control and Prevention. Targeting epilepsy: one of the nation's most common disabling neurological conditions 2007. Revised April 2007. Available at http://www.cdc.gov/nccdphp/publications/AAG/epilepsy.htm [Last accessed 19 February 2008]
5. FineSmith RB. Community-based antiepileptic treatment in the developmentally disabled. In: Devinsky O, Westbrook L, eds. Epilepsy and Developmental Disabilities. Boston, MA: Butterworth-Heinemann, 2002:287-294
6. Stokes T, Shaw EJ, Juarez-Garcia A, et al. Clinical Guidelines and Evidence Review for the Epilepsies: diagnosis and management in adults and children in primary and secondary care. National Collaborating Center for Primary Care. London: Royal College of General Practitioners, October 2004
7. National Institute for Clinical Excellence. The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care. Clinical Guideline 20. National Collaborating Center for Primary Care. October 2004. Available at: www.nice.org.uk/guidance/index.jsp?action= byID&o=10954 [Last accessed 19 February 2008]
8. Epilepsy Foundation. About epilepsy: Treatment options. Available at: http://www.epilepsyfoundation.org/about/treatment [Last accessed 25 March 2008]
9. Pellock JM. Understanding co-morbidities affecting children with epilepsy. Neurology 2004;62(Suppl 2):S17-23 (Pubitemid 38298934)
10. LaRoche SM, Helmers SL. The new antiepileptic drugs: clinical applications. JAMA 2004;291:615-620 (Pubitemid 38500316)
11. Ronen GM, Streiner DL, Rosenbaum P. Health-related quality of life in childhood epilepsy: moving beyond seizure control with minimal adverse effects. Health Qual Life Outcomes 2003;1:36 (Pubitemid 39111960)
12. Rowan AJ. Epilepsy in older adults. Common morbidities influence development, treatment strategies, and expected outcomes. Geriatrics 2005;60:30-2, 34
13. Patsalos PN, Fröscher W, Pisani F, et al. The importance of drug interactions in epilepsy therapy. Epilepsia 2002;43:365-385 (Pubitemid 34297175)
14. French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy. Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2004;62:1261-1273
15. French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy. Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2004;62:1252-1260
16. Lipton RB, Stewart WF. Migraine headaches: epidemiology and comorbidity. Clin Neurosci 1998;5:2-9 (Pubitemid 28106786)
17. Epilepsy Foundation. Mood disorders and epilepsy. Available at: http://www.epilepsyfoundation.org/about/related/mood [Last accessed 19 February 2008]
18. Kanner AM. Depression and epilepsy: a new perspective on two closely related disorders. Epilepsy Currents 2006;6:141-146
19. American Academy of Neurology.AANGuideline Summary for Patients and Their Families. Efficacy and tolerability of the new antiepileptic drugs for treatment of new onset epilepsy. Available at: http://www.aan.com/professionals/ practice/pdfs/patient-ep-onset-c.pdf [Last accessed 19 February 2008]
20. Cloyd J, Hauser W, Towne A, et al. Epidemiological and medical aspects of epilepsy in the elderly [review]. Epilepsy Res 2006;68(Suppl 1):S39-48 (Pubitemid 43143412)
21. Bergey GK. Initial treatment of epilepsy: special issues in treating the elderly. Neurology 2004;63(10 suppl 4):S40-48 (Pubitemid 39532362)
22. Sankar R. Initial treatment of epilepsy with antiepileptic drugs: pediatric issues. Neurology 2004;63(Suppl 4):S30-39 (Pubitemid 39532361)
23. Shinnar S, Pellock JM. Update on the epidemiology and prognosis of pediatric epilepsy. J Child Neurol 2002;17(Suppl 1):S4-17 (Pubitemid 34460806)
24. Smith MC. Optimizing therapy of seizures in children and adolescents with developmental disabilities. Neurology 2006;67:S52-S55 (Pubitemid 44967999)